Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches

SIMPLE SUMMARY: Non-small cell lung cancer is the most common type of lung cancer. Anaplastic Lymphoma Kinase (ALK) rearrangements have been found in 5–6% of non-small cell lung cancers. While ALK rearranged non-small cell lung cancer is exquisitely sensitive to ALK directed targeted therapies, it i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sankar, Kamya, Nagrath, Sunitha, Ramnath, Nithya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004790/
https://www.ncbi.nlm.nih.gov/pubmed/33806977
http://dx.doi.org/10.3390/cancers13061476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004790/
https://www.ncbi.nlm.nih.gov/pubmed/33806977
http://dx.doi.org/10.3390/cancers13061476

Ejemplares similares